Thromboelastometric Monitoring of the Hemostatic Effect of Platelet Concentrates Transfusion in Thrombocytopenic Children Undergoing Chemotherapy

• Published in: Clinical and applied thrombosis/hemostasis Vol. 21; no. 6; pp. 558 - 564
• Main Authors: Ziegler, Bernhard, Solomon, Cristina, Cadamuro, Janne, Jones, Neil
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.09.2015; SAGE PUBLICATIONS, INC
• Subjects: Adolescent; Chemotherapy; Child; Female; Humans; Male; Monitoring, Physiologic - methods; Neoplasms - blood; Neoplasms - drug therapy; Original; Platelet Count; Platelet Transfusion; Thrombelastography; Thrombocytopenia - blood; Thrombocytopenia - chemically induced; Thrombocytopenia - therapy; platelet function; thrombocytopenia; hemostasis
• ISSN: 1076-0296; 1938-2723
• DOI: 10.1177/1076029614564862

Prophylactic platelet concentrates transfusion represents a therapeutic choice in patients with chemotherapy-induced thrombocytopenia. This prospective, non-interventional study evaluated the effects of platelet concentrates transfusion on thromboelastometric parameters of platelet function in 36 transfusion occasions for 11 thrombocytopenic children undergoing chemotherapy. Pre- and posttransfusion (1-2 hours) blood samples were analyzed using standard coagulation tests and thromboelastometry (ROTEM) measurements (EXTEM and FIBTEM tests). Platelet component of the clot was calculated based on the EXTEM and FIBTEM maximum clot elasticity (MCE) results. After transfusion, mean platelet count increased from 16.5 × 109/L to 43.0 × 109/L (P < .001) and platelet component increased from 34.1 to 73.0 (P < .001). Statistically significant increases for posttransfusion EXTEM parameters A10, A20, and maximum clot firmness (MCF) were observed compared to pretransfusion values (P < .001). The EXTEM α-angle values increased posttransfusion (P < .05). The FIBTEM measurements were comparable pre- and posttransfusion. The study showed that platelet concentrates transfusion in thrombocytopenic children undergoing chemotherapy improves platelet-related coagulation pattern.